LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,514 | -21.3% | 10,334 | +4.2% | 0.00% | – |
Q4 2022 | $4,464 | -93.6% | 9,920 | -87.4% | 0.00% | – |
Q3 2022 | $70,000 | -21.3% | 78,627 | +1.5% | 0.00% | – |
Q2 2022 | $89,000 | -92.7% | 77,463 | -88.9% | 0.00% | – |
Q1 2022 | $1,224,000 | +25.9% | 699,354 | +133.1% | 0.00% | – |
Q4 2021 | $972,000 | +98.8% | 300,034 | +146.4% | 0.00% | – |
Q3 2021 | $489,000 | +264.9% | 121,750 | +48.7% | 0.00% | – |
Q2 2021 | $134,000 | +83.6% | 81,881 | +113.2% | 0.00% | – |
Q1 2021 | $73,000 | – | 38,409 | +426666.7% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 9 | -99.9% | 0.00% | – |
Q3 2020 | $12,000 | -42.9% | 6,009 | -40.0% | 0.00% | – |
Q2 2020 | $21,000 | – | 10,009 | +76892.3% | 0.00% | – |
Q1 2020 | $0 | – | 13 | -23.5% | 0.00% | – |
Q4 2019 | $0 | – | 17 | +41.7% | 0.00% | – |
Q3 2019 | $0 | – | 12 | +33.3% | 0.00% | – |
Q2 2019 | $0 | – | 9 | -75.0% | 0.00% | – |
Q1 2019 | $0 | – | 36 | -41.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 61 | -46.5% | 0.00% | – |
Q3 2018 | $1,000 | -66.7% | 114 | -77.2% | 0.00% | – |
Q2 2017 | $3,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 900,733 | $1,883,000 | 1.44% |
Sio Capital Management, LLC | 1,501,998 | $3,139,000 | 0.92% |
CVI Holdings, LLC | 704,900 | $1,473,000 | 0.55% |
Perceptive Advisors | 8,476,496 | $17,466,000 | 0.28% |
Artal Group S.A. | 2,974,000 | $6,216,000 | 0.17% |
SPHERA FUNDS MANAGEMENT LTD. | 880,000 | $1,839,000 | 0.17% |
DAFNA Capital Management LLC | 275,000 | $575,000 | 0.17% |
J. Goldman & Co LP | 1,018,285 | $2,128,000 | 0.13% |
MYDA Advisors LLC | 100,000 | $209,000 | 0.13% |
683 Capital Management, LLC | 526,466 | $1,100,000 | 0.09% |